Reshema Kemps-Polanco - 01 Feb 2024 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Director
Signature
/s/Matthew Daniel as attornery-in-fact for Reshema Kemps-Polanco
Issuer symbol
CRL
Transactions as of
01 Feb 2024
Net transactions value
+$87,596
Form type
4
Filing time
05 Feb 2024, 20:31:48 UTC
Previous filing
30 Jan 2024
Next filing
15 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $0 +170 $0.000000 170 01 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $87,596 +399 $219.54 399 01 Feb 2024 Common Stock 399 $219.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 170 unvested restricted stock units that vest on 5/7/2024.
F2 The stock options become exercisable 5/7/2024.